Sales and Marketing Efforts Pay off for CombiMatrix as Q1 Sales Jump 11 Percent
May 17, 2011
Sales and Marketing Efforts Pay off for CombiMatrix as Q1 Sales Jump 11 Percent
The company attributed the spike in sales to "continued customer acceptance and increased market penetrance from our sales and marketing efforts for our suite of tests."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - CustomArray Nets $200K from NIH to Develop Padlock-Probe Detection System for Cancer Dx
December 13, 2011 / BioArray News - People in the News
September 6, 2011 / BioArray News - CombiMatrix Cleared to Offer Cyto Array Services to New York State Residents
August 9, 2011 / BioArray News - CombiMatrix Prepares Cancer Array for Launch, Inks Sales and Marketing Deal with Clarient
April 12, 2011 / BioArray News